Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) traded up 6.1% during trading on Tuesday after Piper Sandler raised their price target on the stock from $55.00 to $62.00. The stock traded as high as $52.45 and last traded at $51.88. 1,516 shares changed hands during trading, a decline of 99% from the average session volume of 211,870 shares. The stock had previously closed at $48.88.
Separately, Zacks Investment Research cut shares of OrthoPediatrics from a “hold” rating to a “sell” rating in a research report on Friday, March 12th. One research analyst has rated the stock with a sell rating and three have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $54.50.
In other news, President David R. Bailey sold 4,769 shares of OrthoPediatrics stock in a transaction that occurred on Monday, March 1st. The shares were sold at an average price of $55.84, for a total transaction of $266,300.96. Following the sale, the president now owns 88,373 shares of the company’s stock, valued at approximately $4,934,748.32. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Bernie B. Berry III sold 699 shares of the business’s stock in a transaction that occurred on Thursday, February 25th. The shares were sold at an average price of $57.00, for a total transaction of $39,843.00. Following the completion of the sale, the director now directly owns 32,481 shares in the company, valued at $1,851,417. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 47,686 shares of company stock worth $2,589,408. 33.60% of the stock is owned by corporate insiders.
The stock’s 50-day moving average is $50.21 and its 200 day moving average is $46.70. The stock has a market capitalization of $951.64 million, a PE ratio of -33.62 and a beta of 0.67.
OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Thursday, March 11th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.46). OrthoPediatrics had a negative net margin of 34.26% and a negative return on equity of 11.57%. Sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.26 earnings per share for the current year.
About OrthoPediatrics (NASDAQ:KIDS)
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.